Recent Developments on Protein–Ligand Interactions

From Structure, Function to Applications

Edited by
March 2022
282 pages
  • ISBN978-3-0365-3394-0 (Hardback)
  • ISBN978-3-0365-3393-3 (PDF)

This book is a reprint of the Special Issue Recent Developments on Protein–Ligand Interactions: From Structure, Function to Applications that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology

Protein–ligand interactions play a fundamental role in most major biological functions. The number and diversity of small molecules that interact with proteins, whether naturally or not, can quickly become overwhelming. They are as essential as amino acids, nucleic acids or membrane lipids, enabling a large number of essential functions. One need only think of carbohydrates or even just ATP to be certain. They are also essential in drug discovery. With the increasing structural information of proteins and protein–ligand complexes, molecular modelling, molecular dynamics, and chemoinformatics approaches are often required for the efficient analysis of a large number of such complexes and to provide insights. Similarly, numerous computational approaches have been developed to characterize and use the knowledge of such interactions, which can lead to drug candidates. "Recent Developments on Protein–Ligand Interactions: From Structure, Function to Applications" was dedicated to the different aspect of protein–ligand analysis and/or prediction using computational approaches, as well as new developments dedicated to these tasks. It will interest both specialists and non-specialists, as the presented studies cover a very large spectra in terms of methodologies and applications. It underlined the variety of scientific area linked to these questions, i.e., chemistry, biology, physics, informatics, bioinformatics, structural bioinformatics and chemoinformatics.

  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
pimaricin thioesterase; protein-substrate interaction; macrocyclization; molecular dynamics (MD) simulation; pre-reaction state; folate; folate receptor; peptide conjugation; click reaction; biolayer interferometry; acetylcholinesterase; resistance; organophosphorus; pesticides; molecular modeling; lepidopterous; insects; conserved patterns; similarity; 3D-patterns; epigenetics; protein-RNA interaction; RRM domain inhibitor; NMR fragment-based screening; TDP-43; galectin-1; gulopyranosides; fluorescence polarization; benzamide; selective; phospholipase C gamma 1; SLP76; virtual screening; pharmacophore mapping; molecular docking; molecular dynamics; caspase inhibition; protein-ligand binding free energy; Monte Carlo sampling; docking and scoring; molecular conformational sampling; procollagen C-proteinase enhancer-1; glycosaminoglycans; computational analysis of protein-glycosaminoglycan interactions; calcium ions; fragment-based docking; protein–ligand analysis; drug discovery and design; structure–activity relationships; bioremediation; High Energy Molecules; HMX; protein design; molecular dynamics; nitroreductase; flavoprotein; substrate specificity; pharmacophore; molecular dynamics; virtual screening; secretoglobin; odorant-binding protein; chemical communication; pheromone; N-phenyl-1-naphthylamine; in silico docking; molecular modeling; protein–ligand interactions; 2D interaction maps; ligand-binding assays; protein-ligand complexes; dataset; clustering; structural alignment; refinement; PD-1/PD-L1; immune checkpoint inhibitors; biphenyl-conjugated bromotyrosine; amino acid conjugation; amino-X; in silico simulation; IC50